PharmaBoardroom

Key legal info on biosimilars & biologics in China. Prepared in association with Fangda Partners, one of China’s most prestigious and…

Want to know more about localization in China? Prepared in association with Fangda Partners, one of China’s most prestigious and well-regarded law…

An intro to the legal situation for orphan drugs and rare diseases in China. Prepared in association with Fangda Partners, one of China’s most…

Cannabinoid drugs, medicinal cannabis & opioid drugs in India - a comprehensive legal overview. Prepared in association with Fangda Partners, one…

The key facts about regulatory reforms in Chinese pharma. Prepared in association with Fangda Partners, one of China’s most prestigious and…

An outline of the legal situation around patents and trademarks for pharmaceuticals in China. Prepared in association with Fangda Partners, one of…

A comprehensive guide to the legal implications around product liability in China. Prepared in association with Fangda Partners, one of China’s…

A legal intro to traditional medicines and OTC products in China. Prepared in association with Fangda Partners, one of China’s most prestigious and…

A brief overview of the situation regarding marketing, manufacturing, packaging & labeling and advertising within Chinese pharma. Prepared in…

The essential requirements for conducting preclinical and clinical trials in China. Prepared in association with Fangda Partners, one of China’s…

An intro to the regulatory, pricing and reimbursement scenario for pharmaceuticals in China. Prepared in association with Fangda Partners, one of…

The latest news from Chinese pharma, including Fosun Pharma’s 2021 interim results; how AstraZeneca, Bayer, Eli Lilly, Merck & Co., Novartis,…